Sector: MedicalEli Lilly and Company (NYSE: LLY)
Ranking History
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 229 |
Technical : | 3 |
Performance : | 243 |
Overall: | 182 |
Number of Stocks: | 306 |
Scan Date: | 10/20/2009 |
Sector: | Medical |
Funamental : | 241 |
Technical : | 89 |
Performance : | 241 |
Overall: | 233 |
Number of Stocks: | 305 |
Scan Date: | 10/15/2009 |
Sector: | Medical |
Funamental : | 243 |
Technical : | 64 |
Performance : | 256 |
Overall: | 225 |
Number of Stocks: | 305 |
Headlines
- EpiCept Corporation Names Bernard Tyrrell as Senior Vice President, Sales and Marketing
Nov 06, 2009 12:01 AM | AZN, EPCT, JNJ, LLY
- Widespread Generic Erosion of Atypical Antipsychotics Will Cause the Bipolar Disorder Drug Market to Decline By More Than $1 Billion Through 2018
Nov 05, 2009 08:03 AM | AZN, LLY, PFE
- Sirius Genomics received NRC-IRAP Funding for Continued Development of a Sepsis Companion Diagnostic
Nov 05, 2009 07:58 AM | LLY
- Driven by the Launch of Targeted Agents, the Gastric Cancer Drug Market Will More Than Double to Nearly $1.5 Billion in 2018
Nov 04, 2009 08:02 AM | GSK, LLY, NVS
- Cutting Edge Information Sees Burst of Innovation From Pharma and Biotech, Studies Regulatory Atmosphere
Nov 03, 2009 12:13 PM | LLY
- Pharmaceutical Speaker Programs an Important Source of Medical Education, Says Cutting Edge Information
Nov 03, 2009 09:12 AM | LLY, NYT
- Trading Outlook for Avanir Pharmaceuticals Inc. Issued by InvestorSoup.com
Nov 03, 2009 06:51 AM | AMGN, GSK, LLY
- LILLY (ELI) & COMPANY - STATEMENT ON FDA'S BYETTA (EXENATIDE) INJECTION UPDATE
Nov 03, 2009 02:02 AM | AMLN, LLY
- Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDA's BYETTA(R) (Exenatide) Injection Update
Nov 02, 2009 03:30 PM | AMLN, LLY
- LILLY (ELI) & COMPANY - BYETTA Apprd Expand Use 1st-Line Trtmnt Type 2 Diabetes
Nov 02, 2009 08:20 AM | LLY
- The Indianapolis Star Daniel Lee Column: Indiana Working to Create Its Own Identity With Investors
Oct 25, 2009 11:53 AM | LLY, VC
- Eli Lilly to pay S. Carolina $45 million
Oct 24, 2009 02:43 PM | LLY
- Lilly Q3 Net Income Up
Oct 23, 2009 12:54 PM | LLY
- Eli Lilly CEO banking on new drug pipeline
Oct 22, 2009 01:54 PM | LLY, PFE
- Earnings Preview: Bristol-Myers 3Q earnings report
Oct 21, 2009 11:53 AM | AZN, BMY, GSK, JNJ, LLY, MRK
- The Business Diary
Oct 19, 2009 01:55 AM | AMGN, BA, FRX, LLY, MTB, NTRS
- Drug makers, CVS slammed for promos
Oct 18, 2009 05:47 PM | AZN, CVS, LLY, MRK
- Eli Lilly to sell plant, saving 700 jobs
Oct 14, 2009 02:35 PM | LLY
- Indianapolis Prize 2010 nominees announced
Oct 07, 2009 12:55 PM | LLY
- Most see heart attack as wake-up call
Sep 22, 2009 04:11 PM | LLY
- ConocoPhillips up 21% Since Added to Galtstock Long-Term Portfolio
Nov 05, 2009 11:53 AM | COP, LLY, RIG, WMT
- Phase Forward Reports Third Quarter 2009 Results
Oct 29, 2009 04:56 PM | AGN, AZN, CVD, LLY, PFWD, PG
- Bristol-Myers Squibb Achieves Strong Sales, Earnings Performance in Third Quarter
Oct 22, 2009 07:51 AM | AZN, BMY, GILD, LLY
- Licensing Executives Society Announces 2009 Deals of Distinction Awards
Oct 21, 2009 03:52 PM | AGN, LLY, UTHR
- Best Practices to Speed-Up Pharmaceutical Analysis Processes From Johnson & Johnson, Pfizer, Genentech and Eli Lilly at Pharma IQ's Forum on Laboratory Informatics
Sep 30, 2009 11:58 AM | JNJ, LLY, PFE
- PHT Corporation Promotes Dwight Cooper to Vice President of Client Services
Sep 24, 2009 09:57 AM | LLY
- Teva Provides Update on Generic Evista® Litigation
Sep 24, 2009 06:54 AM | LLY, TEVA
- Deltagen Reports 2009 Second Quarter Financial Results
Sep 18, 2009 07:51 PM | LLY, PFE
- Transition Therapeutics Announces Fiscal 2009 Year End Financial Results
Sep 16, 2009 04:53 PM | LLY, TTHI
- Symyx Joins SAFE-BioPharma to Ensure Safe Security Standards for ELN Software; Pharmaceutical Industry Non-Profit Maintains Standards and Certification for Digital Signatures
Sep 15, 2009 04:52 PM | AMGN, AZN, JNJ, LLY, PFE, SMMX
- Form 4 HOOVER R DAVID For: Oct 30 (10K)
Nov 02, 2009 10:08 AM
- Form 4 Fyrwald J Erik For: Oct 30 (10K)
Nov 02, 2009 10:04 AM
- Form 4 HOOVER R DAVID For: Aug 31 (10K)
Aug 31, 2009 11:39 AM
- Form 4 Fyrwald J Erik For: Aug 31 (10K)
Aug 31, 2009 11:35 AM
- Form 4 HOOVER R DAVID For: Jul 31 (10K)
Aug 03, 2009 12:56 PM
- Form 4 Fyrwald J Erik For: Jun 30 (10K)
Jul 01, 2009 02:14 PM
- Form 3 Peterson Barton R For: Jun 15 (10K)
Jun 19, 2009 05:57 PM
- Form 3 HOOVER R DAVID For: Jun 01 (10K)
Jun 11, 2009 12:48 PM
- Form 4 Fyrwald J Erik For: May 29 (10K)
May 29, 2009 11:08 AM
- Form 3 Mahony Susan For: May 01 (10K)
May 06, 2009 04:47 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
LLY
|
Compare to S&P
|
| YTD |
-15.55 %
|
-26.38 %
|
| 4 Weeks |
4.61 %
|
3.51 %
|
| 12 Weeks |
-2.52 %
|
-4.94 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 7.14 %
|
|
EPS Growth in Last Year: 15.38 %
|
|
Sales Growth in Last Quarter: 5.09 %
|
|
Sales Growth in Last Quarter: 6.77 %
|
|
